24/7 Market News Snapshot 01 July, 2025 – Venus Concept Inc. Common Stock (NASDAQ:VERO)

July 1, 2025

DENVER, Colo., 01 July, 2025 (www.247marketnews.com) – (NASDAQ:VERO) are discussed in this article.
Shares of Venus Concept Inc. (NASDAQ:VERO) have shown a remarkable performance recently, opening at $2.32 and soaring up to $3.556, representing an increase of over 50%. This surge is accompanied by a trading volume of 2.96 million shares, reflecting strong investor interest and optimism regarding the company’s prospects in medical aesthetics technology.

In a pivotal move to further strengthen its financial position, Venus Concept recently executed a strategic exchange of $6.5 million of subordinated convertible notes with affiliates of Madryn Asset Management, LP. This transaction resulted in the issuance of 325,651 shares of Series Y preferred stock and marks a significant reduction of approximately 14% in the company’s overall debt, bringing it down to around $34.3 million from $39.7 million at the year’s close.

Rajiv De Silva, Chief Executive Officer of Venus Concept, underscored the strategic importance of this debt reduction initiative, stating, “We continue to optimize our capital structure with this debt exchange that lowers our overall debt burden. The support from Madryn has provided us with the financial flexibility necessary to facilitate our transformation, including the recent divestiture of our Venus Hair business, as we aim for sustainable long-term growth and profitability.”

Avinash Amin, Managing Partner at Madryn Asset Management, reiterated their commitment to supporting Venus Concept’s strategic direction, expressing enthusiasm for the company’s growth trajectory. The emphasis remains on scaling the business as Venus Concept continues to offer innovative, minimally invasive medical aesthetic technologies across more than 60 countries.

With ongoing efforts to enhance its product portfolio and commercial operations, Venus Concept is positioning itself as a leading entity in the rapidly evolving medical aesthetic industry. The strong market reaction to its recent stock performance and strategic financial decisions underscores the momentum building behind the company’s future endeavors.

Related news for (VERO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.